Optimizing Prograf® Therapy in Renal Transplant Patients

A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients

NCT00717678 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic Studies of Tacrolimus in Transplant Patients

NCT01889758 ·Status: COMPLETED ·Phase: PHASE4

A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal Recipients

NCT01742676 ·Status: COMPLETED ·Phase: PHASE4

A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)

NCT02147938 ·Status: COMPLETED

Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation

NCT01742624 ·Status: COMPLETED ·Phase: PHASE4

A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients

NCT00650468 ·Status: COMPLETED ·Phase: PHASE4

Minimizing Immunosuppression in Old for Old Kidney Transplantation

NCT00912678 ·Status: COMPLETED ·Phase: PHASE4

A Randomized Study Assess the Safety and Efficacy of Tacrolimus vs Prograf® in Renal Transplantation Treatment

NCT01244659 ·Status: WITHDRAWN ·Phase: PHASE3

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients

NCT00282568 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAF

NCT01839929 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients

NCT00282230 ·Status: TERMINATED ·Phase: PHASE2

A Comparison of the Effects of Extended Release Tacrolimus (Advagraf®) vs. Immediate Release Tacrolimus (Prograf®) on Kidney Function in Healthy Male Volunteers

NCT01681134 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients

NCT01256294 ·Status: COMPLETED ·Phase: PHASE4

A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

NCT01363752 ·Status: COMPLETED ·Phase: PHASE4

Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients

NCT02953873 ·Status: COMPLETED ·Phase: PHASE4

Advagraf/Prograf Conversion Trial

NCT01410162 ·Status: COMPLETED ·Phase: PHASE4

Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine

NCT03527238 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule

NCT02268201 ·Status: TERMINATED ·Phase: PHASE4

Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation

NCT00717379 ·Status: COMPLETED ·Phase: PHASE4

Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

NCT01294020 ·Status: COMPLETED ·Phase: PHASE2

Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism

NCT02311010 ·Status: UNKNOWN ·Phase: PHASE4

A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients

NCT00384137 ·Status: COMPLETED ·Phase: PHASE3

Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®

NCT01332201 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients

NCT02706678 ·Status: COMPLETED ·Phase: PHASE4

Prograf-Advagraf Cross Over Conversion Study

NCT01797341 ·Status: COMPLETED ·Phase: PHASE3